Ambu fails to live up to revenue forecasts
The number of endoscopes sold is significantly higher than what the market had predicted in Ambu's second quarter. However, this has not brought about the kind of revenue that analysts had expected. The full-year outlook is maintained.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
Ambu maintains its full-year outlook following a Q2 in which revenue totaled DKK 1bn.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Analyst believes in continued progress for Ambu
For subscribers
Olympus targets carbon neutrality by 2030
For subscribers
